KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.7%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $6,000 | 0.0% | 869 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | -25.0% | 869 | -48.9% | 0.00% | – |
| Q1 2019 | $8,000 | 0.0% | 1,701 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -50.0% | 1,701 | +3.0% | 0.00% | -100.0% |
| Q3 2018 | $16,000 | -30.4% | 1,652 | -2.6% | 0.00% | -50.0% |
| Q2 2018 | $23,000 | -14.8% | 1,696 | -0.7% | 0.00% | – |
| Q1 2018 | $27,000 | +145.5% | 1,708 | +199.1% | 0.00% | -100.0% |
| Q4 2017 | $11,000 | -77.1% | 571 | -14.5% | 0.00% | -66.7% |
| Q3 2017 | $48,000 | – | 668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,333,333 | $5,073,000 | 100.00% |
| CAXTON CORP | 1,483,343 | $5,644,000 | 6.36% |
| Polaris Venture Management Co. V, L.L.C. | 1,197,032 | $4,555,000 | 2.59% |
| RA Capital Management | 4,537,478 | $17,265,000 | 1.03% |
| Orbimed Advisors | 3,447,840 | $13,119,000 | 0.25% |
| Matisse Capital | 46,500 | $177,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 332,831 | $1,266,000 | 0.22% |
| Sofinnova Investments, Inc. | 478,206 | $1,819,000 | 0.16% |
| HARBOURVEST PARTNERS LLC | 99,186 | $377,000 | 0.16% |
| ALGERT GLOBAL LLC | 47,195 | $180,000 | 0.07% |